Updated:
Riverhill Fund
RiverHill Fund is a venture capital fund founded by Simon XIE, a co-founder of Alibaba. It focuses on investments in TMT startups at the angel and A round...
Riverhill Fund
RiverHill Fund is a venture capital fund founded by Simon XIE, a co-founder of Alibaba. It focuses on investments in TMT startups at the angel and A round stages. The fund's portfolio includes companies in O2O, SNS, media, business intelligence, and other sectors.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Hangzhou
Corporate office
Hangzhou, China
Frequently asked questions
Does Riverhill Fund invest in public equities or late-stage rounds?
No. Riverhill concentrates solely on private, early-stage seed and start-up investments. There is no indication of participation in public market strategies, late-stage growth equity, or buyout structures.
How does Riverhill Fund source its early-stage deal flow?
Sourcing methods are not publicly documented. Given the firm's Hangzhou location and early-stage focus, deal flow likely originates through founder networks, local incubators, and personal introductions rather than through formal intermediary processes or advisor-led auctions.
Who is responsible for investment decisions at Riverhill Fund?
Key decision-makers are not disclosed in public records or on the firm's website. Principal names and investment committee composition remain unverifiable through available sources.
Does Riverhill Fund accept capital from external limited partners?
The firm's investor base is not disclosed. Minimal online presence suggests fundraising is conducted through private, offline channels, likely from domestic Chinese high-net-worth individuals or family offices rather than through broad institutional LP solicitation.
What differentiates Riverhill structurally from larger Chinese VC firms?
Riverhill operates as a pure early-stage specialist, writing small checks at the seed and start-up level. This positions the firm one step earlier in the funding lifecycle than China's better-known multi-stage managers. The absence of later-stage or public-markets capabilities means the firm cannot follow portfolio companies through growth rounds, creating a dependency on subsequent institutional investors to price and support the next financing.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: